EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Era of Gene Therapy: The Advancement of Lentiviral Vectors and Their Pseudotyping

Bat-Erdene Jargalsaikhan iD, Masanaga Muto, Masatsugu Ema iD

Viruses · 2025

DOI: 10.3390/v17081036 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Viruses, 2025. Verfasst von Bat-Erdene Jargalsaikhan und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stem Cells and Human Disease Models, Research Center for Animal Life Science, Shiga University of Medical Science, Seta, Tsukinowa-cho,…. Hauptthemen laut MEDLINE: Genetic Therapy, Genetic Vectors, Lentivirus. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 303 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Over 35 years of history, the field of gene therapy has undergone much progress. The initial concept—the replacement of dysfunctional genes with correct ones—has advanced to the next stage and reached the level of precise genome editing. Dozens of gene therapy products based on viral and non-viral delivery platforms have been approved, marking the dawn of the gene therapy era. These viral vector strategies rely on adenoviruses, adeno-associated viruses, lentivirus-derived tools, and so on. From the middle of the gene therapy transition, despite the challenges and serious negative consequences, the lentiviral vector has emerged as a cornerstone and demonstrated benefits in fields ranging from basic science to gene therapy. Therefore, we outline the importance of lentiviral vectors in the gene therapy era by focusing on their roles in the clinical usage, derivation, and development of next-generation platforms, as well as their pseudotyping.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Genetic TherapyGenetic VectorsLentivirusHumansAnimalsGene Editing

Stichwörter der Autor:innen

envelope proteinsgene therapylentiviral vectorspseudotyping

Autor:innen und Institutionen

  • Department of Stem Cells and Human Disease Models, Research Center for Animal Life Science, Shiga University of Medical Science, Seta, Tsukinowa-cho, Otsu 520-2192, Japan.
  • Medical Genome Center, National Cerebral and Cardiovascular Center, 6-1 Kishibe-Shinmachi, Suita 564-8565, Japan.
  • Institute for the Advanced Study of Human Biology (ASHBi), Kyoto University, Yoshida-Konoe-cho, Sakyo-ku, Kyoto 606-8501, Japan.

ORCID-Profile: Bat-Erdene Jargalsaikhan, Masatsugu Ema

Zitieren

APA

Jargalsaikhan, B. E., Muto, M., & Ema, M. (2025). The Era of Gene Therapy: The Advancement of Lentiviral Vectors and Their Pseudotyping. Viruses. https://doi.org/10.3390/v17081036

Vancouver

Jargalsaikhan BE, Muto M, Ema M. The Era of Gene Therapy: The Advancement of Lentiviral Vectors and Their Pseudotyping. Viruses. 2025. doi:10.3390/v17081036

BibTeX
@article{Jargalsaikhan2025,
  author = {Jargalsaikhan, Bat-Erdene and Muto, Masanaga and Ema, Masatsugu},
  title = {The Era of Gene Therapy: The Advancement of Lentiviral Vectors and Their Pseudotyping},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17081036}
}
Kostenlos starten →